Protein-C-Mangel

I. Pabinger-Fasching

doi:10.1055/s-0038-1655115

Hämostaseologie, Inhaltsverzeichnis

Hamostaseologie 1985; 05(04): 134-138
DOI: 10.1055/s-0038-1655115

Originalarbeiten

Schattauer GmbH

Protein-C-Mangel

I. Pabinger-Fasching

¹I. Medizinische Universitätsklinik (Vorstand: Prof. Dr. Dr. h. c. E. Deutsch), Abteilung für Hämatologie und Blutgerinnung, Wien

LITERATUR
1 Stenflo J. A new vitamin K dependent protein. J. Biol. Chem 251: 355-363 1976;
2 Kisiel W. Human protein C: Isolation, characterization and mechanism of activation. J. Clin. Invest 64: 761-769 1979;
3 Esmon C. T, Stenflo J, Suttie J. W. A new vitamin K dependent protein. J. Biol. Chem 251: 3052-3056 1975;
4 Mammen J. F, Thomas W. R, Seegers W. H. Activation of purified prothrombin to autoprothrombin II-A. Thromb. Diath. Haemorrh 05: 218-250 1960;
5 Seegers W. H, McCoy E. L, Groben H. D, Sakuragawa N, Agrawal B. B. L. Purification and some properties of autoprothrombin II-A: An anticoagulant perhaps also related to fibrinolysis. Thromb. Res 01: 443-460 1972;
6 Dahlbäck B, Stenflo J. Inhibitory effect of activated protein C on activation of prothrombin by platelet-bound cofactor Xa. Eur. J. Biochem 107: 331-335 1980;
7 Dahlbäck B, Stenflo J. Inhibitory effect of activated protein C on activation of prothrombin by platelet-bound cofactor Xa. Eur. J. Biochem 107: 331-335 1980;
8 Esmon C. T, Owen W. G. Identification of an endothelial cell cofactor for thrombin catalized activation of protein C. Proc. Natl. Acad. SCi. USA 78: 2245-2252 1981;
9 Esmon C. T, Esmon N. L, Harris K. W. Complex formation between thrombomodulin inhibits both thrombin-catalyzed fibrin formation and F V activation. J. Biol. Chem 257: 7944-7947 1982;
10 Esmon N. L, Roger C. C, Esmon C. T. Thrombomodulin blocks the ability of thrombin to activate platelets. J. Biol. Chem 258: 1238-1242 1983;
11 Marlar R. A, Kleiss A. J, Griffin J. H. Mechanism of action of activated protein C, a thrombin dependent anticoagulant enzyme. Blood 59: 1062-1072 1982;
12 Suzuki K, Stenflo J, Dahlbäck B, Teodorsson B. Inactivation of human coagulation factor V by activated protein C.J. Biol. Chem 258: 1914-1920 1983;
13 Fulcher C. A, Gardiner E. J, Griffin J. H, Zimmermann T. S. Proteolytic inactivation of human F VIII procoagulant protein by activated protein C and its analogy with F.V. Blood 63: 486-489 1984;
14 Comp P. C, Esmon C. T. Activated protein C inhibits platelet prothrombin converting activity. Blood 54: 1272-1281 1979;
15 Dahlbäck B, Stenflo J. Inhibitory effect of activated protein C on activation of prothrombin by platelet-bound cofactor Xa. Eur. J. Biochem 107: 331-335 1980;
16 Fletcher B. T, Lockhart M. S. A new function for activated protein C: Activated protein C prevents inhibition of plasminogen activators by release from mononuclear leukocytes - platelet suspensions stimulated by phorbol diester. Thromb. Res 37: 155-164 1985;
17 Fletcher B. T, Lockhart M. S. Whole blood clot lysis: In vitro modulation by activated protein C. Thromb. Res 37: 639-649 1985;
18 Comp P. C, Esmon C. T. Initiation of clot lysis in plasma by activated protein C. Circulation 57/58 (Suppl. II): 210 1978;
19 Comp P. C, Esmon C. T. Generation of in vivo fibrinolytic activity by infusion of activated protein C into dogs. Circulation 62 (Suppl. Ill): 334 1980;
20 Walker F. J. Regulation of activated protein C by a new protein. A possible function for bovine protein S.J. Biol. Chem 255: 5521-5524 1980;
21 Schwarz H. P, Fischer M, Hoppmeier P, Batard M. A, Griffin J. H. Plasma protein S deficiency in familial thrombotic disease. Blood 64: 1297-1300 1984;
22 Comp P. C, Esmon C. T. Recurrent venous thromboembolism in patients with a partial deficiency of protein S.N. Engl. J. Med 311: 1525-1528 1984;
23 Broekmans A. W, Bertina R. M, Reinalda-Poot J, Engesser L, Muller H. P, Leeuw J. A, Michiels J. J, Brommer E. J. P, Briet E. Hereditary protein S deficiency and venous thrombo-embolism. Thromb. Haemost. (in press
24 Marlar R. A, Griffin J. H. Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease. J. Clin. Invest 66: 1186-1189 1980;
25 Griffin J. H, Evatt B, Zimmermann T. S, Kleiss A. J, Wideman C. Deficiency of protein C in congenital thrombotic disease. J. Clin. Invest 68: 1370-1373 1981;
26 Vikydal R, Korninger C, Kyrie P. A, Niessner H, Pabinger I, Thaler E, Lechner K. The prevalence of hereditary antithrombin Ill-deficiency in patients with a history of venous thromboembolism. Thromb. Haemostas.. 1985 in press
27 Broekmanns A. W, Yeltkamp J. J, Bertina R. M. Congenital protein C deficiency and venous thromboembolism. A study in three Dutch families. N. Engl. J. Med 309: 340-344 1983;
28 Pabinger-Fasching I, Bertina R. M, Lechner K, Niessner H, Korninger C. Protein C deficiency in two Austrian families. Thromb. Haemost 50: 810-813 1983;
29 Horellou M. H, Conard J, Bertina R. M, Samama M. Congenital protein C deficiency and thrombotic disease in nine French families. Brit. Med. J 289: 1285-1287 1984;
30 Boyer C, Rothschild C, Wolf M, Amiral J, Meyer D, Larrieu M. J. A new method for the estimation of protein C by ELISA. Thromb. Res 36: 579-589 1984;
31 Bertina R. M. A, Broekmanns W, van Es-Krommenhoek C, van Wijngaarden A. The use of functional and immunological assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency. Thromb. Haemost 51: 1-5 1984;
32 Sala N, Owen W. G, Collen D. A functional assay of protein C in human plasma. Blood 63: 671-675 1984;
33 Francis R. B, Patch M. J. A functional assay for protein C in human plasma. Thromb. Res 32: 605-613 1983;
34 Comp P. C, Nixon R. R, Esmon C. T. Determination of functional levels of protein C, an antithrombotic protein, using thrombin-thrombomodulin complex. Blood 63: 15-21 1984;
35 Mannucci P. M, Vigano S. Deficiencies of protein C, an inhibitor of blood coagulation. Lancet II: 463-466 1982;
36 Polack B, Pouzol P, Amiral J, Kolo-die L. Protein C level at birth. Thromb. Haemost 52: 188-190 1984;
37 Mannucci P. M, Vigano S, Bottasso B, Candotti G, Bozzetti P, Rossi E, Pardi G. Protein C. Antigen during pregnancy, delivery and puerperium. Throm. Haemost 52: 217 1984;
38 Vikydal R, Korninger C, Kyrie P. A, Niessner H, Pabinger I, Thaler E, Lechner K. The prevalence of hereditary antithrombin Ill-deficiency in patients with a history of venous thromboembolism. Thromb. Haemostas.. 1985 in press
39 Estelles S, Garcia-Plaza I, Dasi A, Aznar J, Duart M, Sanz G, Perez-Requejo J. L, Espana F, Jimenez C, Abele-do G. Severe inherited »homozygous« protein C deficiency in a newborn infant. Thromb. Haemost 52: 53-56 1984;
40 Marciniak E, Wilson H. D, Marlar R. A. Neonatal purpura fulminans: A genetic disorder related to the absence of protein C in blood. Blood 65: 15-20 1985;
41 Vikydal R, Korninger C, Kyrie P. A, Niessner H, Pabinger I, Thaler E, Lechner K. The prevalence of hereditary antithrombin Ill-deficiency in patients with a history of venous thromboembolism. Thromb. Haemostas.. 1985 in press
42 Thaler E, Lechner K. Antithrombin III deficiency and thromboembolism. Clin. Haemat 10: 369-390 1981;
43 Vikydal R, Korninger C, Kyrie P. A, Niessner H, Pabinger I, Thaler E, Lechner K. The prevalence of hereditary antithrombin Ill-deficiency in patients with a history of venous thromboembolism. Thromb. Haemostas.. 1985 in press
44 Griffin J. H, Mosher D. F, Zimmermann T. S, Kleiss A. J. Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation. Blood 60: 261-264 1982;
45 Vigano S, Manucci P. M, Solinas S, Bottasso B, Mariani G. Decrease in protein C antigen and formation of an abnormal protein soon after starting oral anticoagulant treatment. Brit. J. Haemat 57: 213-220 1984;
46 Pabinger-Fasching I, Lechner K. Protein- C-Mangel und Thromboseneigung. Fol. Haematol. Ill 04: 416-420 1984;
47 Loeliger E. A, Broekmanns A. W. Drugs affecting blood clotting, fibrinolysis, and hemostasis. In: Meyler’s side effect of drugs, 659 1984
48 Loeliger E. A, Broekmanns A. W. Drugs affecting blood clotting, fibrinolysis, and hemostasis. In: Meyler’s side effect of drugs 659 1984;
49 Mannucci P. M, Viagno S. Protein C concentrates for therapeutic use. Lancet / 875 1983;
50 McGehee W. G, Klotz T. A, Epstein D. J, Rapaport S. I. Coumarin necrosis associated with hereditary protein C deficiency. Ann. Int. Med 100: 59-60 1984;
51 Mannucci P. M, Viagno S. Protein C concentrates for therapeutic use. Lancet / 875 1983;
52 Katz H. E. JBranson, Marble R, Griffin J. H. Inherited protein C deficiency and coumarin-rèsponsive chronic relapsing purpura fulminans in a newborn infant. Lancet II: 1165-1168 1983;
53 Mannucci P. M, Viagno S. Protein C concentrates for therapeutic use. Lancet / 875 1983;
54 Bertina R. M, Broekmanns A. W. Protein C concentrates for therapeutic use. Lancet II: 1384 1982;
55 Mannucci P. M, Viagno S. Protein C concentrates for therapeutic use. Lancet / 875 1983;
56 Barbui T, Finazzi G, Vigano S, Mannucci P. M. L-Asparaginase lowers protein C antigen. Thromb. Haemost 52: 216 1984;
57 Barbui T, Rodeghiero F, Meli S, Dini E. Fatal pulmonary embolism and antithrombin III deficiency in adult lymphoblastic leukemia during L-Asparaginase therapy. Acta Haematol 69: 188-191 1983;
58 Thaler E, Baizar E, Kopsa H, Pinggera W. E. Acquired antithrombin III deficiency in patients with glomerular proteinuria. Hemostasis 07: 257-272 1978;
59 Pabinger-Fasching I, Lechner K, Niessner H, Schmidt P, Balzar E, Mannhalter C. High levels of plasma protein C in nephrotic syndrome. Thromb. Haemostas 53: 5-7 1985;